Combined oral omega‐3 and omega‐6 PUFAs vs placebo
- Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye disease 2019 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 3 participantsModerate
Combined oral omega‐3 and omega‐6 PUFAs showed no clear difference in schirmer test (aqueous tear production, measured in mm/5 min, with… compared with placebo (moderate certainty).
Vitamin E showed no clear difference in any AMD compared with placebo (high certainty).
It is very uncertain whether beta‐carotene changes neovascular AMD compared with placebo (very low certainty).
It is very uncertain whether beta‐carotene changes geographic atrophy compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Vitamin C showed no clear difference in any AMD compared with placebo (high certainty).
Vitamin C showed no clear difference in late AMD (either neovascular AMD or geographic atrophy or both) compared with placebo (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Vitamin E showed no clear difference in late AMD (either neovascular AMD or geographic atrophy or both) compared with placebo (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Multivitamin probably leads to higher any AMD compared with placebo (moderate certainty).
Multivitamin showed no clear difference in late AMD compared with placebo (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.